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Abstract: Introduction: The role of inflammation in cancer has been defined, and now, 
inflammation is accepted as one of the hallmarks of cancer development. The aim of this 
study was to evaluate the difference regarding preoperative neutrophil to lymphocyte 
(NLR) and platelet to lymphocyte ratios (PLR) in patients with meningioma between 
patients and healthy controls and between grade-I and grade-II meningiomas. Methods: 
Retrospective analysis of preoperative neutrophil, lymphocyte, monocyte, and platelet 
counts and NLR, and PLR were evaluated in 61 patients underwent meningioma surgery. 
Results: Neutrophil count was significantly increased while lymphocyte count 
significantly decreased patients compared to controls. Similar findings were obtained in 
grade-II meningiomas compared with grade-I meningiomas. NLR were significantly 
higher in both grade-I and grade-II meningiomas than controls. Conclusion: We for the 
first time provided that higher NLR may be associated with grading of meningioma and 
be a predictive factor for progression of meningiomas. The use of medication against 
neutrophil-related inflammation may be helpful for patients with higher grade of 
meningioma decreasing peritumoral edema before and after surgery.   
Key words: Inflammation; Meningioma; Neutrophil-lymphocyte ratio; Platelet-
lymphocyte ratio 
 
Introduction 
Meningiomas are the most commonly seen 
intracranial extra-axial tumors, accounting for 
25% of all intracranial space-occupying 
lesions. Females are affected more 
predominantly than males due to estrogen 
functions (1). Although meningiomas are 
accepted as generally benign in nature, the 
recurrence rate in some cases is extremely 
high, even after the total surgical removal of 
the lesion. Thus, in 2007, the World Health 
Organization classified meningiomas into 
three grades. Grade I is more commonly 
encountered when compared to grades II and 
III, and the recurrence rate for grade I tumors 
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is very low. However, in grade II or III tumors, 
a high recurrent rate is common, and 
radiotherapy is required after surgery (2). 
Meningiomas originate in the arachnoid cap 
cells, but the exact nature of the development 
of these common tumors remains unknown. 
The role of inflammation in cancer has 
been defined, and now, inflammation is 
accepted as one of the hallmarks of cancer 
development (3). With regard to inflammation 
in brain tumors, meningiomas have been 
focused on less when compared to gliomas. 
However, recent evidence has suggested that 
inflammation plays a pivotal role in the 
development and progression of brain tumors, 
including gliomas (4, 5). Finding a useful 
biomarker to predict the progression of brain 
tumors would be exciting for a neurosurgeons 
because there has been no such marker used in 
brain tumors, as opposed to certain other solid 
tumors such as breast cancer (6). Recent 
studies have shown that the preoperative 
blood inflammatory markers, such as the 
neutrophil to lymphocyte ratio (NLR) or 
platelet to lymphocyte ratio (PLR), can be used 
as indices of glioma progression. For example, 
it has been reported that a high NLR (increase 
in the neutrophil count and decrease in the 
lymphocyte count) has a diagnostic value, and 
it correlates with the glioma grade (4, 5, 7-10). 
Those studies emphasized the fact that local 
inflammation around the tumor 
microenvironment can be reflected 
systemically, and that the inflammation 
severity can be tested by using peripheral 
blood tests that are cheap, reproducible, and 
effective.  
Surprisingly, there have been no reports 
focusing on the preoperative blood markers in 
intracranial meningiomas. Therefore, in this 
retrospective analysis, we wanted to show how 
the preoperative NLR and PLR levels change 
when compared to the controls. We 
hypothesized that the NLR and PLR would be 
higher in meningiomas cases (compared to 
controls), and that the levels would correlate 
with the meningioma grade, given that the 
same inflammatory processes take place in 
both glioma and meningioma cases.   
Materials and Methods 
Patients 
The patient group included here 
underwent surgeries for intracranial-
supratentorial meningiomas by a single 
surgeon between 2010 and 2017. A total of 100 
cases were retrieved from the medical records, 
but only 61 patients were included, according 
to the following criteria: 1) the meningioma 
grade was verified by a histopathological 
study, 2) no chemotherapy, radiotherapy, and 
steroids were taken before the surgery, 3) no 
co-morbidities or extracranial tumors were 
seen, 4) there was no previous surgery due to 
any intracranial pathology; 5) there was a 
complete blood count (CBC) before surgery; 
and 6) an informed consent form was 
completed. 
Data collection 
The demographic, clinical, radiological 
and histopathological data were retrieved from 
each patient’s medical records. After 
hospitalization, blood samples were taken for 
a CBC and other tests, including hepatic 
function, serology and the electrolyte level, as 
a standard preoperative work-up. The 
neutrophil (103/mm3), lymphocyte 
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(103/mm3), and platelet (103/mm3) counts 
were recorded. Additionally, the preoperative 
NLR (quotient of the absolute number of the 
neutrophil count to the lymphocyte count) 
and PLR (quotient of the absolute number of 
the platelet count to the lymphocyte count) 
were calculated.  
All of the patients underwent cranial 
magnetic resonance imaging (MRI) with 
contrast enhancement. The anterior-posterior 
diameter (cm) was measured by using T1-
weighted contrast-enhanced axial images, and 
the presence of peritumoral edema was noted 
by using T2-weighted and fluid-attenuated 
inversion recovery (FLAIR) images.  
Controls     
The control group in this study was 
composed of 35 subjects who were admitted to 
our clinic and underwent CBC testing for 
some other reason, such as a headache. None 
of the subjects exhibited any abnormalities in 
their cranial MRI scans and no other organ 
system illnesses were detected. The blood 
samples were obtained during their admission 
to our outpatient clinic.  
Statistical Analysis  
The statistical analysis was performed by 
using IBM SPSS Statistics for Windows 
version 22.0 (IBM Corp., Armonk, NY, USA). 
The results were reported here as the mean ± 
standard deviation. An independent samples 
t-test and chi-squared test were used in the 
appropriate comparisons and the correlation 
analysis was judged using Pearson’s 
correlation coefficient. The area under the 
curve (AUC) for the NLR and PLR with a 
receiver operating characteristics (ROC) curve 
analysis was used for the diagnostic 
performance. A probability value (p value) < 
0.05 was considered to be statistically 
significant. 
Results 
Demographic characteristics 
The patient group included 26 males (42.6 
%) and 35 females (57. 4 %) with a mean age of 
51.91 ± 13.01 years old (range = 23 to 76 years). 
The control group had 19 males (54.3 %) and 
16 females (45.7 %) with a mean age of 32.08 ± 
10.09 years old (range = 10 to 51 years).  Based 
on the cranial MRI scans, there were 26 (42.6 
%) and 35 (57.4 %) right and left-sided 
meningiomas, respectively. Peritumoral 
edema was noted in 37 patients (60.7 %). The 
histopathological diagnoses revealed grade I 
meningiomas in 48 patients (78.7 %) and grade 
II in 13 patients (21.3 %). All of the patients 
with grade II meningiomas had peritumoral 
edema. The mean of the anterior-posterior 
diameters of the tumors was 36.73 ± 13.6 cm. 
Inflammatory markers: patients versus controls 
Table I shows a summary of the 
comparisons between the patients and the 
controls with regard to the preoperative 
inflammatory markers studied here. The mean 
of the neutrophil count levels was significantly 
higher in the patients when compared to 
controls (p = 0.001). The lymphocyte and 
platelet counts were lower in the patients; 
however, the differences were not significant. 
As expected, the NLR was significantly higher 
in the patient group (p = 0.001). Moreover, the 
mean PLR level was higher in the patients than 
the controls, but the difference was not 
significant. However, there was a trend toward 
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significance in the PLR levels of the patients (p 
= 0.05). 
Inflammatory markers: meningioma grade 
and edema versus controls 
Given that inflammation has been shown 
to play an important role in upgrading of 
tumors and the presence of peritumoral 
edema, we compared how the preoperative 
inflammatory marker levels change. Table II 
shows that the neutrophil count increases, 
whereas the lymphocyte and platelet counts 
decrease in grade II when compared to grade-
I meningiomas. 
TABLE I 
Preoperative inflammatory markers in patients and controls 
Marker Patients (n = 61) Controls (n = 35) P value 
Neutrophils 5.42 ± 2.63 4.20 ± 0.81 0.001* 
Lymphocytes 2.11 ± 1.09 2.39 ± 0.54 0.15 
Platelets 252.54 ± 76.18 271.57 ± 57.66 0.20 
NLR 3.42 ± 3.62 1.83 ± 0.49 0.001* 
PLR 136.46 ± 57.27 118.51 ± 34.24 0.05 
NLR: Neutrophil-lymphocyte ratio; PLR: Platelet-lymphocyte ratio. 
*Denotes statistically significant difference. 
 
TABLE II 
Preoperative inflammatory markers according to meningioma grade and controls 
Marker Neutrophils Lymphocytes Platelets NLR PLR 
Grade-I 5.14 ± 2.54  2.21 ± 1.13  255.46 ± 61.29  2.75 ± 2.17  128.78 ± 48 
Grade-II 6.45 ± 2.81 1.71 ± 0.82  241.73 ± 118.9  5.90 ± 6.28  164.83 ± 79.15 
Controls 4.20 ± 0.81  2.39 ± 0.54  271.57 ± 67.66   1.83 ± 0.49  118.51 ± 34.24 
Edema+ 5.84 ± 2.96 2.03 ± 0.87 252.82 ± 85.73 4.0 ± 4.47 141.18 ± 66.95 
Edema- 4.77 ± 1.91  2.22 ± 1.37 252.10 ± 60.28 2.52 ± 1.39 129.19 ± 30.07 
Grade-I versus Grade-II 
P value 0.11 0.14 0.69 0.09 0.13 
Grade-I versus Controls 
P value 0.02* 0.4 0.22 0.006* 0.28 
Grade-II versus Controls 
P value 0.01* 0.002* 0.4 0.03* 0.06 
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Edema present versus absent 
P value 0.12 0.49 0.96 0.06 0.37 
NLR: Neutrophil-lymphocyte ratio; PLR: Platelet-lymphocyte ratio. 
*Denotes statistically significant difference. 
Edema+: Presence of peritumoral edema. 
Edema-: Absence of peritumoral edema. 
 
As expected, the NLR and PLR were 
increased in the grade II meningiomas but no 
significant differences were found between 
these two grades. However, there was a trend 
toward significance with regard to the NLR.  
When the grade I meningiomas and the 
controls were compared, we found that the 
neutrophil count and NLR increased, while the 
lymphocyte count, platelet count, and PLR 
decreased in the grade I cases. However, the 
difference reached significance only regarding 
the neutrophil count and NLR. Findings 
supporting the role of inflammation in the 
upgrading of a meningioma were found when 
a comparison between the grade II 
meningiomas and the controls was performed. 
The neutrophil count, platelet count, NLR, 
and PLR were higher and the lymphocyte 
count and platelet count were lower in the 
grade II cases than in the controls. The 
differences were significant regarding the 
neutrophil count and lymphocyte count, and 
NLR levels. The presence and/or absence of 
peritumoral edema caused differences in the 
inflammatory marker levels, but none reached 
a significant level. Here, we must emphasize 
the fact that the neutrophil and lymphocyte 
counts increased and decreased, respectively, 
suggesting that inflammation may play a role 
in the development of peritumoral edema. 
Although we did not find significant 
differences between the presence and absence 
of peritumoral edema with respect to the NLR 
and PLR, both showed elevations in the 
presence of peritumoral edema.  
Correlations    
The strong positive correlations were as 
follows: neutrophil count and NLR (r = 0.65, p 
= 0.00001), neutrophil count and PLR (r = 
0.28, p = 0.005), lymphocyte count and platelet 
count (r = 0.32, p = 0.001), platelet count and 
PLR (r = 0.21, p = 0.03), and NLR and PLR (r 
= 0.61, p = 0.00001). Contrarily, the strong 
negative correlations were as follows: 
lymphocyte count and NLR (r = - 0.47, p = 
0.00001), lymphocyte count and PLR (r = - 
0.63, p = 0.00001), and platelet count and NLR 
(r = - 0.26, p = 0.008). 
Diagnostic efficacy   
When the patients with meningiomas were 
tested against the controls (Figure 1), the 
AUCs were 0.70 [95 % confidence interval (CI) 
0.59-0.80, p = 0.001] for the NLR and 0.57 (95 
% CI = 0.45-0.69, p = 0.22) for the PLR.  
However, when grade I meningiomas were 
tested against the grade II meningiomas  
(Figure 2), the AUCs were 0.70 (95 % CI = 
0.53-0.86) for the NLR and 0.64 (95 % CI = 
0.45-0.83, p = 0.1) for the PLR. The findings 
showed that the NLR exhibited the best 
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accuracy for a meningioma diagnosis and 
predicting the meningioma grade. 
 
 
Figure 1 - ROC curve analysis showing diagnostic 
efficacy when patients with meningioma were tested 
against healthy subjects 
 
 
Figure 2 - ROC curve analysis showing diagnostic 
efficacy when patients with meningioma were tested 
against those with grades I and II 
Discussion 
The role of chronic inflammation in both 
the development and progression of cancer 
has been identified, and it has been strongly 
suggested that inflammation-related 
neutrophils and lymphocytes, as well as 
platelets, participate in angiogenesis and the 
proliferation of tumor cells (11, 12). 
Meningiomas, especially grade I lesions are 
slow-growing tumors, and obviously, chronic 
inflammation may take place in their 
development and progression. However, the 
exact mechanism(s) behind the neutrophilia 
and lymphopenia that are commonly found in 
cancer is poorly understood. Some researchers 
have suggested that the cytokines and 
chemokines secreted by tumor cells can cause 
neutrophil infiltration, thus causing an 
elevation in their counts in both the tumor 
microenvironment and the peripheral blood 
(13, 14). The increased neutrophil levels  
subsequently inhibit the white blood cells, 
including lymphocyte activity, and this leads 
to lymphocyte apoptosis.  
The studies reported during the last decade 
showed that higher neutrophil and lower 
lymphocyte counts are associated with poor 
prognoses in various cancers, including glial 
tumors of the brain (4, 5, 7-10, 15, 16). 
Unfortunately, there have been a limited 
number of studies focusing on brain tumors 
with regard to the preoperative inflammatory 
markers, when compared to the other organ 
system tumors, and there have been no reports 
focusing on meningiomas. A few studies have 
reported the preoperative inflammatory 
markers, such as the NLR, PLR, and 
lymphocyte to monocyte ratio (LMR), in some 
extra-axial tumors, such as vestibular 
schwannomas and craniopharyngiomas (15, 
16). For example, Kontorinis, et al. (15) 
demonstrated that a very high NLR is a reliable 
marker for vestibular schwannoma growth 
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and that it can predict grooving schwannomas. 
Chen, et al. (16) found that the levels of white 
blood cells, neutrophils, NLR, and  PLR were 
higher in craniopharyngiomas when 
compared to other sellar tumors, and they 
emphasized the fact that these markers can be 
used to differentiate craniopharyngiomas. 
Moreover, Zheng et al. (5) provided the first 
evidence that patients with gliomas have 
higher NLR levels than patients with non-
lesional epilepsy, vestibular schwannomas, 
meningiomas, and healthy controls.  
Because there have been no previous 
reports studying preoperative inflammatory 
markers in meningioma cases, we could not 
compare our results with those from the 
current literature. However, we did discuss our 
results with regard to previous reports 
including gliomas. First, we would like to 
emphasize the fact that our results were 
strongly in line with those of other studies 
including patients with gliomas (4, 5, 7-10). A 
significantly higher neutrophil count and NLR 
were found in our patient group when 
compared to the healthy controls. Although 
we did not find a statistically significant 
difference regarding the PLR, there was a trend 
toward significance. The lymphocyte count 
was also lower in the meningioma patients, but 
the difference was not significant. These 
results mentioned above support the previous 
glioma studies in which a higher neutrophil 
count, lower lymphocyte count, higher NLR, 
and, in some studies, a higher PLR were found 
to be strongly associated with  the prognosis 
(5, 8). More importantly, the glioma grade was 
associated with a higher NLR, and it was stated 
that the NLR can be used as an index for 
glioma progression, with an NLR ≥ 4 showing 
a poor prognosis (5, 8).  
It is clear that as tumor grade increases, the 
inflammatory reaction increases and the levels 
of the inflammatory markers, such as the 
neutrophil count, NLR, and PLR, increase. For 
the first time, we demonstrated preoperative 
inflammatory marker levels in different 
meningioma grades (grade I and II). We 
obtained very supportive findings that 
malignancy increases, the inflammation-
related markers increase. The grade II patients 
showed higher and lower levels of neutrophils 
and lymphocytes, respectively, when 
compared to the grade I patients, but more 
importantly, the NLR and PLR were higher in 
the grade II patients although the differences 
were not significant. This may be due to the 
fact that the number of grade II patients (n = 
13) was smaller than that of the grade I patients 
(n = 48). We believe that if we were able to 
include an equal number of patients in each 
grade, the differences would be significant. 
The neutrophil counts and NLR were also 
clearly higher in each grade when compared to 
the healthy subjects but the biggest differences 
were found when comparing the grade II and 
the healthy subjects, suggesting that 
inflammation may play a role in tumor 
progression, as in the current literature on 
glioma patients (4, 5, 7-10).  
From a clinical standpoint, we know that as 
the tumor malignancy increases, the 
peritumoral edema, which can sometimes 
cause life-threatening conditions, increases. 
Recent studies have shown that inflammatory 
cells play roles in the formation of peritumoral 
edema, and they have been found in 
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edematous tissues (17). We hypothesized that 
because peritumoral edema is associated with 
inflammation, the levels of the inflammatory 
markers studied here, would increase in those 
patients who exhibited peritumoral edema on 
their cranial MRI scans. We note the fact that 
peritumoral edema was observed in all 13 of 
the patients who were diagnosed with grade II 
meningiomas. The neutrophil count and 
lymphocyte count were increased and 
decreased, respectively, in the patients with 
peritumoral edema when compared to those 
who had no peritumoral edema, and there 
were higher NLR and PLR levels in those 
patients with peritumoral edema. These 
finding supported our hypothesis that 
inflammation may play an important role in 
the development of peritumoral edema, and 
an anti-edematous treatment including  a 
medication inhibiting neutrophil action in 
addition to steroids would be beneficial.  
As in the few studies including extra-axial 
tumors, such as vestibular schwannomas and 
craniopharyngiomas (15, 16), and the studies 
including gliomas (4, 5, 7-10), the NLR 
compared to the PLR exhibited the highest 
diagnostic value in predicting meningiomas. 
This can differentiate grade I meningiomas 
from grade II meningiomas, and it could be 
used as an index for possible tumor 
progression after surgery. 
Limitations 
The authors contributed to this study are 
aware that there are a few limitations. First, 
this is a retrospective study that may cause 
selection bias although we had strict selection 
criteria. Second, our patient sample consisted 
of a relatively small number of patients with 
meningioma, in particular, limited number of 
grade I meningiomas thus the literature needs 
prospective studies with larger cohort of 
meningioma patients. Third, higher levels of 
neutrophil count, NLR, and PLR can be a 
reflection of non-specific inflammatory 
response due to meningioma thus we have a 
risk of having false-positive results. We 
underline that until we have enough number 
of studies including larger cohort of patients, 
the results obtained from the current literature 
and from the present study should be 
evaluated carefully. 
Conclusion 
Apart from the limitations mentioned 
above, we for the first time provided that 
higher NLR may be associated with grading of 
meningioma and a predictive factor for 
progression of meningiomas. The use of 
medication against neutrophil-related 
inflammation may be helpful for patients with 
higher grade of meningioma for decreasing 
peritumoral edema before and after surgery. 
We were not able to compare our results with 
the current literature due to absence of studies 
included same type of tumor. Thus, further 
studies are needed.  
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